Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Cysteine Protease
    (1)
  • HIV Protease
    (5)
  • MMP
    (1)
  • PKC
    (1)
  • Protease-activated Receptor
    (1)
  • Others
    (11)
Filter
Search Result
Results for "

product2/HIV-Protease.html

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    24
    TargetMol | Activity
  • Peptide Products
    7
    TargetMol | inventory
  • Recombinant Protein
    24
    TargetMol | natural
Cysteine protease inhibitor-2
T10924612048-23-4In house
Cysteine protease inhibitor 2 is a cysteine protease inhibitor. Cysteine protease inhibitor 2 inhibited DCT116 and PC3 cells with GI50 values of 6.5 μM and 4.4 μM, respectively.
  • $1,520
6-8 weeks
Size
QTY
Protease-Activated Receptor-2, amide
T7513190383-13-2
Protease-Activated Receptor-2, amide (SLIGKV-NH2) is an agonist of PAR2 with an IC50 of 10.4 M.
  • $48
In Stock
Size
QTY
TargetMol | Inhibitor Sale
HIV-1 protease-IN-9
T792952925381-27-5
HIV-1 protease-IN-9 (compound 5b), a potent HIV-1 protease inhibitor, exhibits strong antiviral efficacy with a dissociation constant (K_i) of 0.028 nM and a half-maximal inhibitory concentration (IC_50) of 66.8 nM [1].
  • $1,370
8-10 weeks
Size
QTY
HIV-1 protease-IN-11
T795362925287-54-1
HIV-1 protease-IN-11 (compound 34a), an HIV-1 protease inhibitor, demonstrates potent inhibition with an IC50 of 0.41 nM and maintains substantial efficacy against a drug-resistant variant [1].
  • $1,970
8-10 weeks
Size
QTY
Protease-Activated Receptor-1 antagonist 2
T742661454588-34-1
Protease-Activated Receptor-1 Antagonist 2 is an orally active antagonist of protease-activated receptor-1 (PAR-1), demonstrating significant potency with an IC 50 of 7 nM. It exhibits favorable pharmacokinetic characteristics, making it valuable in cardiovascular disease (CVD) research, including studies on atherosclerosis and restenosis [1].
  • Inquiry Price
Size
QTY
HIV-1 protease-IN-7
T749422916441-36-4
HIV-1 protease-IN-7 (compound 16) is an orally active HIV-1 protease inhibitor with an IC50 of 3.52 nM and an EC50 of 37 nM [1].
  • Inquiry Price
8-10 weeks
Size
QTY
TNF Protease Inhibitor 2
TQ0129187034-31-7
TAPI-2 is a broad-spectrum inhibitor of MMP (IC50: 20 μM), tumour necrosis factorα-converting enzyme (TACE) and a disintegrin and metalloproteinase (ADAM).
  • Inquiry Price
Size
QTY
HIV Protease Substrate 1 TFA
T76074
HIV Protease Substrate 1 TFA, a fluorogenic substrate for HIV protease, facilitates the investigation of the enzyme's activity [1].
  • Inquiry Price
Size
QTY
HIV-1, HIV-2 Protease Substrate
T76502149639-49-6
HIV-1, HIV-2 Protease Substrate serves as a substrate for the proteases of both HIV-1 and HIV-2, featuring four residues that permit conservative substitutions at the enzyme substrate binding sites [1].
  • Inquiry Price
Size
QTY
HIV-1 protease-IN-12
T795372925287-59-6
HIV-1 protease-IN-12 (compound 35b) is a potent HIV-1 protease inhibitor with an IC50 value of 0.51 nM, demonstrating efficacy against drug-resistant variants [1].
  • $1,970
8-10 weeks
Size
QTY
HIV protease-IN-1
T749392511547-82-1
HIV protease-IN-1 (compound 1·succinate), a potent non-peptidic inhibitor of HIV protease, is used in AIDS research [1].
  • Inquiry Price
Size
QTY
HIV Protease Substrate 1
T39729223769-59-3
HIV Protease Substrate 1 is a fluorogenic compound that offers insights into the enzymatic activity of HIV protease, making it a valuable tool for studying this aspect.
  • $1,520
Backorder
Size
QTY
HIV-1 protease-IN-5
T641122525173-96-8
HIV-1 protease-IN-5 is an HIV-1 protease inhibitor (IC50: 1.64 nM). HIV-1 protease-IN-5 exhibits significant effects on wild-type and DRV-resistant HIV-1.
  • $1,520
6-8 weeks
Size
QTY
HIV-1 protease-IN-1
T634532765293-30-7
HIV-1 protease-IN-1 is a potent inhibitor of HIV-1 protease (IC50: 90 pM). HIV-1 protease-IN-1 has antiviral activity against B-HIV (EC50: 89 nM): HIV-1 protease-IN-1 was able to act on C-HIV strain ZM246 (EC50: 13.59 nM) and C-HIV strain Indie (EC50: 8.23 nM).
  • $2,140
6-8 weeks
Size
QTY
Protease-Activated Receptor-1 antagonist 2
T64285
Protease-Activated Receptor-1 antagonist 2 is a selective, orally active PAR-1 antagonist (IC50: 7 nM) with favorable pharmacokinetic properties, suitable for cardiovascular disease (CVD) research such as atherosclerosis and restenosis studies.
  • $1,520
10-14 weeks
Size
QTY
HIV-1 protease-IN-2
T639492248124-46-9
HIV-1 protease-IN-2 is a potent inhibitor of HIV-1 protease (IC50: 2.53 nM) and exhibits antiviral effects against DRV (Darunavir) sensitive and drug-resistant HIV-1 mutants.
  • $2,140
6-8 weeks
Size
QTY
HIV Protease Substrate I
T76485124077-63-0
HIV Protease Substrate I, a chromogenic substrate for HIV-1 protease, contains the protease's cleavage site [1].
  • Inquiry Price
Size
QTY
HIV-1 protease-IN-8
T789502925287-55-2
HIV-1 protease-IN-8 (compound 34b) is a potent inhibitor of the HIV-1 protease enzyme with an IC50 of 0.32 nM. It exhibits IC50 values of 0.29 μM for the wild-type HIV-1 (HIV-1 NL4-3) and 1.90 μM against a drug-resistant variant (HIV-1 MDR), indicating strong antiviral activity against both strains [1].
  • $1,970
8-10 weeks
Size
QTY
HIV-1 protease-IN-6
T63733
HIV-1 protease-IN-6 (compound 17d) is a potent HIV-1 protease inhibitor with an IC50 of 21 pM and a Ki of 4.7 pM, demonstrating significant antiviral activity against DRV (darunavir) resistant mutants, surpassing its inhibition efficacy against wild-type viruses.
  • $1,520
10-14 weeks
Size
QTY
HIV-1 protease-IN-4
T74488
HIV-1 protease-IN-4 (Compound II-22), a potent inhibitor of the HIV-1 protease, acts as a prodrug for atazanavir and significantly enhances its bioavailability in rat plasma, achieving a 5-fold increase in the area under the curve (AUC) and a 67-fold increase in concentration at 24 hours (C24) compared to oral administration of atazanavir alone [1].
  • Inquiry Price
Size
QTY
HIV-IN-2
T742822756838-41-0
HIV-IN-2 (Compound 100) is a potent inhibitor of HIV, demonstrating significant potential for research into HIV infection [1].
  • Inquiry Price
Size
QTY
Hepatitis Virus C NS3 Protease Inhibitor 2
T39503208939-95-1
Hepatitis Virus C NS3 Protease Inhibitor 2, a peptide inhibitor derived from a product targeting the NS3 protease of the hepatitis C virus (HCV), exhibits inhibitory activity with a Ki value of 41 nM.
  • $1,520
Backorder
Size
QTY
HIV Protease Substrate IV
T76511128340-47-6
HIV Protease Substrate IV, a substrate for HIV (human immunodeficiency virus) protease, facilitates the measurement of HIV-1 protease activity [1].
  • Inquiry Price
Size
QTY
HIV-1 protease-IN-10
T79493
HIV-1 protease-IN-10 (Compound 2) exhibits HIV-1 latency reversing activity (IC50: 0.22 μM), selectively binds to the PKCδ C1b domain (IC50: 0.69 μM), and demonstrates stability against esterase-mediated hydrolysis [1].
  • Inquiry Price
Size
QTY